NoBsRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: shoppers who want every compounded GLP-1 price published before they start an intake
NoBsRx scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. It charges from $115 a month; its compounded semaglutide, at $149, is 25% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
microdose tier; standard plans start at $149/mo
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
NoBsRx is an online GLP-1 service that runs its intake on OpenLoop Health's telehealth platform and fills prescriptions through four compounding pharmacies it names in its Terms. Its pitch is price transparency: every program is priced on its site before you start, at the same price at any dose. Compounded semaglutide injections are $149 a month, oral semaglutide $174 and tirzepatide $225, with low-dose programs at $115; brand Zepbound and Ozempic pens are $1,299 and $1,199. The site does not name the company behind it.
Is NoBsRx legit?
NoBsRx does not name the company behind it anywhere on its site or in its legal pages, so we could not confirm who you would be buying from. We found no FDA warning letters issued under the NoBsRx name. We rate it 7.5/10 overall, across six areas from price to trust and safety. Find out who operates it before you pay, and raise any doubts with a licensed clinician.
Is there a NoBsRx promo or coupon code?
We know of no promo or coupon code for NoBsRx. Its listed price is $115 a month. Coupon sites advertising "NoBsRx discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how NoBsRx compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to NoBsRx
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Editorial score · methodology
NoBsRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral semaglutide option
- Starting price
- $115/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- FDA status
- No FDA warning letters found
How NoBsRx scores
Six columns, each one computed from something NoBsRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
7.1/10$149/month is 25% below the $199 median for compounded semaglutide across the sellers we compare. A cheaper microdose price is also listed; Value is scored on the standard dose.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on NoBsRx
Last checked October 2026- Checked the listed price across 8 dose or plan tiers
- Checked FDA warning letters for NoBsRx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with NoBsRx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1NoBsRx shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask NoBsRx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: semaglutide $115, tirzepatide $115. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that NoBsRx serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting NoBsRx
- Phone
- 1-808-518-3894
- NoBsRx offers email support
Cancelling NoBsRx
Taken from the terms NoBsRx publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Month to month, or prepaid 12, 24 or 52-week terms (low-dose programs: month to month or 12 weeks); auto-renews until canceled by email before the renewal date
- Refund policy
- "Subscription fees for the current billing period are generally non-refundable once a billing period has begun."
- Early-termination fee
- None
Medications NoBsRx lists
NoBsRx lists Ozempic, Zepbound, compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Same price at every dose. Prepay options: $390 for 12 weeks, $790 for 24 weeks or $1,551 for 52 weeks, charged upfront. A $20 first-order code (FB20) runs through October 31.
Same price at every dose. Prepay options: $497 for 12 weeks, $987 for 24 weeks or $1,893 for 52 weeks, charged upfront. NoBsRx does not say whether the oral form is a tablet, drops or a dissolving film.
Same price at every dose. Prepay options: $548 for 12 weeks, $1,142 for 24 weeks or $2,225 for 52 weeks, charged upfront.
A separate low-dose program, not the standard weight-loss plan. Also sold as $340 for 12 weeks, charged upfront.
A separate low-dose program, not the standard weight-loss plan. Also sold as $340 for 12 weeks, charged upfront.
A separate low-dose oral program. Also sold as $340 for 12 weeks, charged upfront.
Brand-name Eli Lilly pen, with the provider consult, shipping and messaging included.
Brand-name Novo Nordisk pen, FDA-approved for type 2 diabetes; consult, shipping and messaging included.
Check the price yourself before you pay
Every figure here comes from NoBsRx's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $149 a month, 25% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $225 a month, 16% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- We found no FDA warning letters issued to NoBsRx
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What NoBsRx charges
NoBsRx charges $115/month for its microdose tier; its standard plans start at $149/month and hold that rate across every dose.
- Compounded semaglutide (injection): $149/month
- Compounded semaglutide (oral): $174/month
- Compounded tirzepatide (injection): $225/month
- Compounded semaglutide (microdose injection): $115/month
- Compounded tirzepatide (microdose injection): $115/month
- Compounded semaglutide (microdose oral): $115/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so NoBsRx's $149 is genuinely below the middle, not just advertised that way. Before you pay, compare NoBsRx's cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
bmiMD, at about $129/month, is the closest like-for-like alternative we review.
What NoBsRx dispenses
NoBsRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The choice is between an FDA-approved pen and a compounded preparation that costs less. Compounding is lawful and often appropriate, but a compounded product is not an approved one, and the price gap is largely that difference. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy. NoBsRx also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at NoBsRx at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
NoBsRx tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to NoBsRx. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If NoBsRx will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether NoBsRx bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- injections are the thing keeping you from starting
Our read
NoBsRx competes on price without an obvious sacrifice elsewhere: $149/month for compounded semaglutide, no FDA warning letters.
The Bottom Line
NoBsRx scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. It charges from $115 a month; its compounded semaglutide, at $149, is 25% below the $199 median among the sellers we compare.
Before you pay NoBsRx
Starting at $115 a month. Check today's price, then start the intake.
Where NoBsRx is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider WellMedRx (from $49/mo).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to NoBsRx sets more sellers in the same category beside NoBsRx on price, states and what the price includes.
Frequently Asked Questions
How to check NoBsRx yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this NoBsRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See NoBsRx's current pricing
Plans start at $115 a month. Whether you qualify is a clinician's decision, made after your intake.